Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

Clinical trial NCT06863259 · RECRUITING

Trial details

NCT number: NCT06863259
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2025-05-21
Primary completion: 2028-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.